HCMV: Persistence in the population: Potential transplacental transmission

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 814-830

  Pereira, Lenore ^a   Maidji, Ekaterina ^a   Fisher, Susan J ^a   Mc Donagh, Susan ^a   Tabata, Takako ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929261862     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.046     Document Type: Chapter

References (84)

1. Ahlfors, K., Ivarsson, S. A., Harris, S. et al. (1984). Congenital cytomegalovirus infection and disease in Sweden and the rela-tiveimportanceofprimaryandsecondarymaternalinfections. Preliminary findings from a prospective study. Scand. J. Infect. Dis., 16, 129-137.
2. Barel, M. T., Pizzato, N., Van Leeuwen, D., Bouteiller, P. L., Wiertz, E. J., and Lenfant, F. (2003). Amino acid compo-sition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation. Eur. J. Immunol., 33, 1707-1716.
3. Bass, K. E., Li, H., Hawkes, S. P. et al. (1997). Tissue inhibitor of metalloproteinase-3 expression is upregulated during human cytotrophoblast invasion in vitro. Dev. Genet., 21, 61-67.
4. Benirschke, K. and Kaufmann, P. (2000). Pathology of the Human Placenta. 4th edn. New York: Springer.
5. Benirschke, K., Mendoza, G. R., and Bazeley, P. L. (1974). Pla-cental and fetal manifestations of cytomegalovirus infection. Virchow's Arch. B Cell Pathol., 16, 121-139.
6. Boppana, S. B. and Britt, W. J. (1995). Antiviral antibody responses and intrauterine transmission after primary mater-nal cytomegalovirus infection. J. Infect. Dis., 171, 1115-1121.
7. Boppana, S. B., Fowler, K. B., Britt, W. J., Stagno, S., and Pass, R. F. (1999) Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics, 104, 55-60.
8. Britt, W. J. (1999). Congenital cytomegalovirus infection. In Sexually Transmitted Diseases and Adverse Outcomes of Pregnancy, P. J. Hitchcock, H. T. MacKay, and J. N. Wasserheit, eds., pp. 269-281. Washington, DC: ASM Press.
9. Bulmer, J. N., Morrison, L., Longfellow, M., Ritson, A., and Pace, D. (1991). Granulated lymphocytes in human endometrium: His-tochemical and immunohistochemical studies. Hum. Reprod., 6, 791-798.
10. Cattaruzza, M., Slodowski, W., Stojakovic, M., Krzesz, R., and Hecker, M. (2003). Interleukin-10 induction of nitric oxide synthase expression attenuates CD40-mediated interleukin-12 synthesis in human endothelial cells. J. Biol. Chem., 11, 11.
11. Chang, C. and Werb, Z. (2001). The many faces of metalloproteases: Cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol., 11, S37-S43.
12. Chou, S. W. and Dennison, K. M. (1991). Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encod-ing neutralization-related epitopes. J. Infect. Dis., 163, 1229-1234.
13. Collier, A. C., Handsfield, H. H., Ashley, R. et al. (1995). Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J. Infect. Dis., 171, 33-38.
14. Cook, C. H., Zhang, Y., McGuinness, B. J., Lahm, M. C., Sedmak, D. D., and Ferguson, R. M. (2002). Intra-abdominal bacte-rial infection reactivates latent pulmonarycytomegalovirus in immunocompetent mice. J. Infect. Dis., 185, 1395-1400.
15. Cross, J. C., Werb, Z., and Fisher, S. J. (1994). Implantation and the placenta: Key pieces of the development puzzle. Science, 266, 1508-1518.
16. Crossey, P. A., Pillai, C. C., and Miell, J. P. (2002). Altered placental development and intrauterine growth restriction in IGF bind-ing protein-1 transgenic mice. J. Clin. Invest., 110, 411-418.
17. Damsky, C. H. and Fisher, S. J. (1998). Trophoblast pseudo-vasculogenesis: Faking it with endothelial adhesion receptors. Curr. Opin. Cell Biol., 10, 660-666.
18. Damsky, C. H., Fitzgerald, M. L., and Fisher, S. J. (1992). Distribu-tion patterns of extracellular matrix components and adhe-sion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J. Clin. Invest., 89, 210-222.
19. Damsky, C. H., Librach, C., Lim, K. H. et al. (1994). Integrin switch-ing regulates normal trophoblast invasion. Development, 120, 3657-3666.
20. Drake, P. M., Gunn, M. D., Charo, I. F. et al. (2001). Human placental cytotrophoblasts attract monocytes and CD56(bright) natural killer cells via the actions of monocyte infiammatory protein 1alpha. J. Exp. Med., 193, 1199-1212.
21. Feire, A. L., Koss, H., and Compton, T. (2004). Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc. Natl. Acad.Sci. USA, 101, 15470-15475.
22. Fish, K. N., Soderberg-Naucler, C., Mills, L. K., Stenglein, S., and Nelson, J. A. (1998). Human cytomegalovirus persistently infects aortic endothelial cells. J. Virol., 72, 5661-5668.
23. Fisher, S., Genbacev, O., Maidji, E., and Pereira, L. (2000). Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: Implications for transmission and patho-genesis. J. Virol., 74, 6808-6820.
24. Fisher, S. J., Leitch, M. S., Kantor, M. S. Basbaum, C. B., and Kramer, R. H. (1985). Degradation of extracellular matrix by the tro-phoblastic cells of first-trimester human placentas. J. Cell. Biochem., 27, 31-41.
25. Fisher, S. J., Cui, T. Y., Zhang, L. et al. (1989). Adhesive and degrada-tive properties of human placental cytotrophoblast cells in vitro. J. Cell. Biol., 109, 891-902.
26. Fowler, K. B. and Pass, R. F. (1991). Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infec-tion. J. Infect. Dis., 164, 259-264.
27. Fowler, K. B., Stagno, S., and Pass, R. F. (2003). Maternal immunity and prevention of congenital cytomegalovirus infection. J. Am. Med. Assoc., 289, 1008-1011.
28. Griffiths, P. D. and Baboonian, C. (1984). A prospective study of primary cytomegalovirus infection during pregnancy: Final report. Br. J. Obstet. Gynaecol., 91, 307-315.
29. Hahn, G., Jores, R., and Mocarski, E. S. (1998). Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA, 95, 3937-3942.
30. Halwachs-Baumann, G., Wilders-Truschnig, M., Desoye, G. et al. (1998). Human trophoblast cells are permissive to the com-plete replicative cycle of human cytomegalovirus. J. Virol., 72, 7598-7602.
31. Hemmings, D. G., Kilani, R., Nykiforuk, C., Preiksaitis, J., and Guil-bert, L. J. (1998). Permissive cytomegalovirus infection of pri-mary villous term and first trimester trophoblasts. J. Virol. 72, 4970-4979.
32. Hoang, V. M., Foulk, R., Clauser, K., Burlingame, A., Gibson, B. W., and Fisher, S. J. (2001). Functional proteomics: Examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry, 40, 4077-4086.
33. Istas, A. S., Demmler, G. J., Dobbins, J. G., and Stewart, J. A. (1995). Surveillance for congenital cytomegalovirus disease: A report from the National Congenital Cytomegalovirus Disease Reg-istry. Clin. Infect. Dis., 20, 665-670.
34. Jones, B. C., Logsdon, N. J., Josephson, K., Cook, J., Barry, P. A., and Walter, M. R. (2002). Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL10R1. Proc. Natl. Acad. Sci. USA, 99, 9404-9409.
35. Jones, T. R. and Muzithras, V. P. (1992). A cluster of dispensable genes within the human cytomegalovirus genome short component: IRS1, US1 through US5, and the US6 family. J. Virol., 66, 2541-2546.
36. Kamat, B. R. and Isaacson, P. G. (1987). The immunocytochem-ical distribution of leukocytic subpopulations in human endometrium. Am. J. Pathol., 127, 66-73.
37. Kammerer, U., Marzusch, K., Krober, S., Ruck, P., Handgretinger, R., and Dietl, J. (1999). A subset of CD56+ large granular lympho-cytes in first-trimester human decidua are proliferating cells. Fertil. Steril., 71, 74-79.
38. Kammerer, U., Schoppet, M., McLellan, A. D. et al. (2000). Human decidua contains potent immunostimulatory CD83(+) den-dritic cells. Am. J. Pathol., 157, 159-169.
39. Kammerer, U., Eggert, A. O., Kapp, M. et al. (2003). Unique appear-ance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am. J. Pathol., 162, 887-896.
40. King, A., Wellings, V., Gardner, L., and Loke, Y. W. (1989). Immuno-cytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the men-strual cycle. Hum. Immunol., 24, 195-205.
41. Kondo, K., Xu, J. and Mocarski, E. S. (1996). Human cytomegalovirus latent gene expression in granulocyte-macrophage progeni-tors in culture and in seropositive individuals. Proc. Natl Acad. Sci. USA, 93, 11137-11142.
42. Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V., and Pestka, S. (2000). Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl Acad. Sci. USA, 97, 1695-1700.
43. Kovats, S., Main, E. K., Librach, C., Stubblebine, M., Fisher, S. J., and DeMars, R. (1990). A class I antigen, HLA-G, expressed in human trophoblasts. Science, 248, 220-223.
44. Kruse, A., Hallmann, R., and Butcher, E. C. (1999). Specialized patterns of vascular differentiation antigens in the pregnant mouse uterus and the placenta. Biol. Reprod., 61, 1393-1401.
45. Lazzarotto, T., Spezzacatena, P., Pradelli, P., Abate, D. A., Varani, S., and Landini, M. P. (1997). Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immuno-compromised subjects. Clin. Diag. Lab. Immunol., 4, 469-473.
46. Lazzarotto, T., Varani, S., Spezzacatena, P. et al. (1998). Delayed acquisition of high-avidity anti-cytomegalovirus antibody is correlated with prolonged antigenemia in solid organ trans-plant recipients. J. Infect. Dis., 178, 1145-1149.
47. Librach, C. L., Werb, Z., Fitzgerald, M. L. et al. (1991). 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J. Cell Biol., 113, 437-449.
48. Librach, C. L., Feigenbaum, S. L., Bass, K. E. etal. (1994). Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J. Biol. Chem., 269, 17125-17131.
49. Maidji, E., Genbacev, O., Chang, H. T., and Pereira, L. (submitted). Developmental regulation of human cytomegalovirus recep-tors in cytotrophoblasts correlates with distinct replication sites in the placenta.
50. Maidji, E., McDonagh, S., Genbacev, O., Tabata, T., and Pereira, L. (2006). Maternal antibodies enhance or pre-vent cytomegalovirus infection in the placenta by neona-tal Fc receptor-mediated transcytosis. Am. J. Pathol., 168, 1210-1226.
51. McDonagh, S., Maidji, E., Ma, W., Chang, H.-T., Fisher, S., and Pereira, L., (2004). Viral and bacterial pathogens at the maternal-fetal interface. J. Infect. Dis., 190, 826-834.
52. McDonagh, S., Maidji, E., Chang, H.-T., and Pereira, L. (2006). Pat-terns of human cytomegalovirus infection in term placentas: A preliminary analysis. J. Clin. Virol., 35, 210-215.
53. McMaster, M. T., Librach, C. L., Zhou, Y. et al. (1995). Human pla-cental HLA-G expression is restricted to differentiated cytotro-phoblasts. J. Immunol., 154, 3771-3778.
54. Mocarski, E. S. (2002). Immunomodulation by cytomegaloviruses: Manipulative strategies beyond evasion. Trends Microbiol., 10, 332-339.
55. Muhlemann, K., Miller, R. K., Metlay, L., and Menegus, M. A. (1992). Cytomegalovirus infection of the human placenta: An immunocytochemical study. Hum. Pathol., 23, 1234-1237.
56. Nakamura, Y., Sakuma, S., Ohta, Y., Kawano, K., and Hashimoto, T. (1994). Detection of the human cytomegalovirus gene in placental chronic villitis by polymerase chain reaction. Hum. Pathol., 25, 815-818.
57. Nigro, G., Adler, S. P., La Torre, R., and Best, A. M. (2005). Passive immunization during pregnancy for congenital cytomegalovirus infection. N. Engl. J. Med., 353, 1350-1362.
58. Norwitz, E. R., Schust, D. J., and Fisher, S. J. (2001). Implantation and the survival of early pregnancy. N. Engl. J. Med., 345, 1400-1408.
59. Pass, B. F. (2001). Cytomegalovirus. In Fields Virology, D. M. Knipe, and P. M. Howley, eds., 4th edn. Vol. 2, pp. 2675-2705. New York: Lippincott-Raven.
60. Pass, R. F., Little, E. A., Stagno, S., Britt, W. J., and Alford, C. A. (1987). Young children as a probable source of maternal and congeni-tal cytomegalovirus infection. N. Engl. J. Med., 316, 1366-1370.
61. Pereira, L., Maidji, E., McDonagh, S., Genbacev, O., and Fisher, S. (2003). Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bac-teria and maternal immunity. J. Virol, 77, 13301-13314.
62. Ploegh, H. L. (1998). Viral strategies of immune evasion. Science, 280, 248-253.
63. Queenan, J. T., Kao, L. C., Arboleda, C. E. et al. (1987). Regulation of urokinase-type plasminogen activator production by cultured human cytotrophoblasts. J. Biol. Chem., 262, 10903-10906.
64. Red-Horse, K., Drake, P. M., Gunn, M. D., and Fisher, S. J. (2001). Chemokine ligand and receptor expression in the pregnant uterus: Reciprocal patterns in complementary cell subsets sug-gest functional roles. Am. J. Pathol., 159, 2199-2213.
65. Redpath, S., Ghazal, P., and Gascoigne, N. R. (2001). Hijacking and exploitation of Il-10 by intracellular pathogens. Trends Micro-biol., 9, 86-92.
66. Revello, M. G., Zavattoni, M., Furione, M., Lilleri, D., Gorini, G., and Gerna, G. (2002). Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infec-tions. J. Infect. Dis., 186, 553-557.
67. Roth, I. and Fisher, S. J. (1999). IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev. Biol., 205, 194-204.
68. Roth, I., Corry, D. B., Locksley, R. M., Abrams, J. S., Litton, M. J., and Fisher, S. J. (1996). Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J. Exp. Med., 184, 539-548.
69. Schust, D. J., Tortorella, D., Seebach, J., Phan, C., and Ploegh, H. L. (1998). Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J. Exp. Med., 188, 497-503.
70. Shen, C. Y., Chang, S. F., Yen, M. S. et al. (1993). Cytomegalovirus excretion in pregnant and nonpregnant women. J. Clin. Micro-biol., 31, 1635-1636.
71. Simister, N. E. and Story, C. M. (1997). Human placental Fc recep-tors and the transmission of antibodies from mother to fetus. J. Reprod. Immunol., 37, 1-23.
72. Simister, N. E., Story, C. M., Chen, H. L., and Hunt, J. S. (1996). An IgG-transporting Fc receptor expressed in the syncytiotro-phoblast of human placenta. Eur. J. Immunol., 26, 1527-1531.
73. Sinzger, C., Muntefering, H., Loning, T., Stoss, H., Plachter, B., and Jahn, G. (1993). Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining. Virchows Archiv. A Pathol. Anat. Histopathol., 423, 249-256.
74. Soderberg-Naucler, C., Fish, K. N., and Nelson, J. A. (1997). Reacti-vation of latent human cytomegalovirus by allogeneic stimu-lation of blood cells from healthy donors. Cell, 91, 119-126.
75. Soderberg-Naucler, C., Streblow, D. N., Fish, K. N., Allan-Yorke, J., Smith, P. P., and Nelson, J. A. (2001). Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differen-tiation dependent. J. Virol., 75, 7543-7554.
76. Soilleux, E. J., Morris, L. S., Lee, B. et al. (2001). Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J. Pathol., 195, 586-592.
77. Soilleux, E. J., Morris, L. S., Leslie, G. et al. (2002). Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol., 71, 445-457.
78. Solberg, H., Rinkenberger, J., Dano, K., Werb, Z., and Lund, L. R. (2003). A functional overlap of plasminogen and MMPs regulates vascularization during placental development. Development, 130, 4439-4450.
79. Spencer, J. V., Lockridge, K. M., Barry, P. A. et al. (2002). Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol., 76, 1285-1292.
80. Stagno, S., Reynolds, D., Tsiantos, A. et al. (1975). Cervical cytomegalovirus excretion in pregnant and nonpregnant women: Suppression in early gestation. J. Infect. Dis., 131, 522-527.
81. Stagno, S., Reynolds, D. W., Pass, R. F., and Alford, C. A. (1980). Breast milk and the risk of cytomegalovirus infection. N. Engl. J. Med., 302, 1073-1076.
82. Stagno, S., Pass, R. F., Dworsky, M. E. et al. (1982). Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N. Engl. J. Med., 306, 945-949.
83. Starkey, P. M., Sargent, I. L., and Redman, C. W. (1988). Cell pop-ulations in human early pregnancy decidua: Characterization and isolation of large granular lymphocytes by fiow cytometry. Immunology, 65, 129-134.
84. Tabata, T., 2006, Cytotrophoblasts infected with a pathogenic human cytomegalovirus strain dysregulate cell-matrix and cell-cell adhesion molecules: A quantitative analysis, Placenta, July 3. (Epub ahead of print).